Ubs Group Ag Pacific Biosciences Of California, Inc. Transaction History
Ubs Group Ag
- $528 Billion
- Q1 2025
A detailed history of Ubs Group Ag transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 2,284,278 shares of PACB stock, worth $2.83 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,284,278
Previous 1,486,015
53.72%
Holding current value
$2.83 Million
Previous $2.72 Million
0.88%
% of portfolio
0.0%
Previous 0.0%
Shares
33 transactions
Others Institutions Holding PACB
# of Institutions
259Shares Held
227MCall Options Held
2.15MPut Options Held
967K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl36.5MShares$45.2 Million0.46% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$29.3 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA23.4MShares$29 Million4.62% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V821.9MShares$27.1 Million0.46% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M020.5MShares$25.4 Million0.08% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $279M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...